Literature DB >> 29443029

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model.

Symantas Ragauskas1, Eva Kielczewski2, Joseph Vance3, Simon Kaja4, Giedrius Kalesnykas5.   

Abstract

Laser-induced choroidal neovascularization (CNV) is a well-established model to mimic the wet form of age-related macular degeneration (AMD). In this protocol, we aim to guide the reader not simply through the technical considerations of generating laser-induced lesions to trigger neovascular processes, but rather focus on the powerful information that can be obtained from multimodal longitudinal in vivo imaging throughout the follow-up period. The laser-induced mouse CNV model was generated by a diode laser administration. Multimodal in vivo imaging techniques were used to monitor CNV induction, progression and regression. First, spectral domain optical coherence tomography (SD-OCT) was performed immediately after the lasering to verify a break of Bruch's membrane. Subsequent in vivo imaging using fluorescein angiography (FA) confirmed successful damage of Bruch's membrane from serial images acquired at the choroidal level. Longitudinal follow-up of CNV proliferation and regression on days 5, 10, and 14 after the lasering was performed using both SD-OCT and FA. Simple and reliable grading of leaky CNV leasions from FA images is presented. Automated segmentation for measurement of total retinal thickness, combined with manual caliber application for measurement of retinal thickness at CNV sites, allow unbiased evaluation of the presence of edema. Finally, histological verification of CNV is performed using isolectin GS-IB4 staining on choroidal flatmounts. The staining is thresholded, and the isolectin-positive area is calculated with ImageJ. This protocol is especially useful in therapeutics studies requiring high-throughput-like screening of CNV pathology as it allows fast, multimodal, and reliable classification of CNV pathology and retinal edema. In addition, high resolution SD-OCT enables the recording of other pathological hallmarks, such as the accumulation of subretinal or intraretinal fluid. However, this method does not provide a possibility to automate CNV volume analysis from SD-OCT images, which has to be performed manually.

Entities:  

Mesh:

Year:  2018        PMID: 29443029      PMCID: PMC5908670          DOI: 10.3791/56173

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice.

Authors:  Robert Hoerster; Philipp S Muether; Sarah Vierkotten; Susanne Schröder; Bernd Kirchhof; Sascha Fauser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-16       Impact factor: 3.117

2.  A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization.

Authors:  Rania S Sulaiman; Judith Quigley; Xiaoping Qi; Michael N O'Hare; Maria B Grant; Michael E Boulton; Timothy W Corson
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-10       Impact factor: 2.671

Review 3.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

4.  A new model of experimental choroidal neovascularization in the rat.

Authors:  E T Dobi; C A Puliafito; M Destro
Journal:  Arch Ophthalmol       Date:  1989-02

5.  Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.

Authors:  M S Seo; N Kwak; H Ozaki; H Yamada; N Okamoto; E Yamada; D Fabbro; F Hofmann; J M Wood; P A Campochiaro
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

6.  In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography.

Authors:  Andrea Giani; Aristomenis Thanos; Mi In Roh; Edward Connolly; George Trichonas; Ivana Kim; Evangelos Gragoudas; Demetrios Vavvas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

7.  Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.

Authors:  T Tobe; N Okamoto; M A Vinores; N L Derevjanik; S A Vinores; D J Zack; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-01       Impact factor: 4.799

8.  Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse.

Authors:  Kristopher G Sheets; Yongdong Zhou; Monica K Ertel; Eric J Knott; Cornelius E Regan; Jasmine R Elison; William C Gordon; Per Gjorstrup; Nicolas G Bazan
Journal:  Mol Vis       Date:  2010-03-02       Impact factor: 2.367

9.  A Mouse Model for Laser-induced Choroidal Neovascularization.

Authors:  Ronil S Shah; Brian T Soetikno; Michelle Lajko; Amani A Fawzi
Journal:  J Vis Exp       Date:  2015-12-27       Impact factor: 1.355

10.  Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice.

Authors:  Yan Gong; Jie Li; Ye Sun; Zhongjie Fu; Chi-Hsiu Liu; Lucy Evans; Katherine Tian; Nicholas Saba; Thomas Fredrick; Peyton Morss; Jing Chen; Lois E H Smith
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

  10 in total
  4 in total

1.  Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling.

Authors:  Dan-Yang Chen; Ning-He Sun; Xiang Chen; Jun-Jie Gong; Song-Tao Yuan; Zi-Zhong Hu; Nan-Nan Lu; Jakob Körbelin; Kohji Fukunaga; Qing-Huai Liu; Ying-Mei Lu; Feng Han
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

2.  Inhibition of choroidal neovascularization by systemic delivery of gold nanoparticles.

Authors:  Rupesh Singh; Julia C Batoki; Mariya Ali; Vera L Bonilha; Bela Anand-Apte
Journal:  Nanomedicine       Date:  2020-04-17       Impact factor: 5.307

3.  CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.

Authors:  Karolina Losenkova; Akira Takeda; Symantas Ragauskas; Marc Cerrada-Gimenez; Maria Vähätupa; Simon Kaja; Marius L Paul; Constanze C Schmies; Georg Rolshoven; Christa E Müller; Jouko Sandholm; Sirpa Jalkanen; Giedrius Kalesnykas; Gennady G Yegutkin
Journal:  Cell Mol Life Sci       Date:  2022-02-25       Impact factor: 9.207

4.  Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration.

Authors:  Amanda Acevedo-Jake; Siyu Shi; Zain Siddiqui; Sreya Sanyal; Rebecca Schur; Simon Kaja; Alex Yuan; Vivek A Kumar
Journal:  Bioengineering (Basel)       Date:  2021-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.